Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Stryker Corp (SYK) AI Forecast

Our AI detected a significant signal for Stryker Corp. Create a free account to see the exact price target.

Free account • 30-day free trial

$SYK Neutral Signal Full forecast available

Stryker Corp (SYK) AI Stock Price Forecast & Investment Analysis

Stryker Corp Stock Price Chart and Technical Analysis

Loading chart...

Stryker Corp (SYK) - Comprehensive Stock Analysis & Investment Research

Deep dive into Stryker Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on June 17, 2026, 10:03 a.m. (UTC)

Stryker Corp Investment Summary

When evaluating whether Stryker Corp (SYK) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Stryker Corp (SYK) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $120 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Stryker Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Stryker Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Stryker Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Stryker Corp

Sign Up Free
Corporate Identity

Stryker Corp (Stock Symbol: SYK) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Stryker Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Stryker Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Stryker Corp...

Unlock Full Company Profile

Get complete details about Stryker Corp

Sign Up Free
Revenue & Growth Analysis

Stryker Corp generates annual revenues of $25 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Stryker Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Stryker Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Stryker Corp...

Unlock Financial Analysis

Get complete financial metrics for Stryker Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Stryker Corp's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Stryker Corp strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Stryker Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company demonstrates exceptional operational efficiency through free cash flow generation of $5 billion annually . This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.

Margin & Pricing Power Analysis

The company maintains a 67.5% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of 23.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.

Asset Utilization Efficiency

Asset turnover ratio of 0.55x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 2.11 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Stryker Corp (SYK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Stryker Corp stock analysis.

Deep dive into Stryker Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Stryker Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Stryker Corp: With a P/E ratio of 35.87, the market highly values future growth prospects.

P/E Ratio 35.87x
P/B Ratio 5.21x
Market Cap $119.69B
Dividend Yield 1.09%
Book Value/Share $59.95
Revenue/Share $65.92
FCF/Share $11.92
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Stryker Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Stryker Corp: An ROE of 10.0% indicates room for improvement in shareholder value creation.

ROE 10.0%
ROA 5.0%
ROIC 7.7%
Gross Margin 67.5%
Operating Margin 23.8%
Net Margin 17.7%
EBT Margin 24.3%
Tax Rate 27.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Stryker Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Stryker Corp: A current ratio of 2.11 indicates strong liquidity.

Current Ratio 2.11x
Quick Ratio 1.25x
D/E Ratio 1.01x
Financial Leverage 2.01x
Interest Coverage 6.6x
Working Capital $7.02B
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Stryker Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Stryker Corp: Free cash flow of $4571M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1.82B
Free Cash Flow $4.57B
Capital Spending $2.75B
FCF/Sales 18.1%
CapEx/Sales 10.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Stryker Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Stryker Corp: An asset turnover of 0.55x suggests room for improvement in asset utilization.

Asset Turnover 0.55x
Receivables Turnover 7.1x
Inventory Turnover 0.8x
Fixed Assets Turnover 6.5x
Days Sales Outstanding 52 days
Days Inventory 470 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Stryker Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Stryker Corp: With annual revenue of $25270M, Stryker Corp operates at significant scale.

Income Statement
Total Revenue $25.27B
Operating Income $3.08B
Net Income $2.29B
R&D Expense $652M
SG&A Expense $4.93B
Cost of Goods Sold $4.21B
Balance Sheet Highlights (% Of Assets)
Total Current Assets 13338%
Cash & Short-term Investments 2878%
Total Liabilities 23312%
Accounts Receivable 3571%
Inventory 5419%
Dividend & Shareholder Information
Dividends Per Share $3.39
Payout Ratio 0.5%
Shares Outstanding 383M
Growth Metrics (YoY)
Net Income Growth 17.7%

Latest Stryker Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Stryker Corp (SYK) stock price and investment outlook.

📰 We are currently updating our news feed for Stryker Corp. Check back soon for the latest market analysis and company updates.

Stryker Corp Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Stryker Corp against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $16M x 2.8x
Aethlon Medical Inc AEMD ██% $5M x 0.9x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $8M x x
Autonomix Medical, Inc. AMIX ██% $5M x 0.8x
Angiodynamics Inc ANGO ██% $506M x 2.9x
Anika Therapeutics, Inc. ANIK ██% $191M x 1.4x
Artivion, Inc. AORT ██% $1.03B 88.2x 2.3x
Apyx Medical Corp APYX ██% $174M x 13.5x
Accuray Inc ARAY ██% $40M x 1.0x
Alphatec Holdings, Inc. ATEC ██% $1.30B x x
Atricure, Inc. ATRC ██% $1.42B x 2.9x
Nuo Therapeutics, Inc. AURX ██% $48M x x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $10.54B x 1.7x
Beta Bionics, Inc. BBNX ██% $622M x 2.3x
Becton Dickinson & Co BDX ██% $40.00B 35.2x 1.7x
Heartbeam, Inc. BEAT ██% $40M x 63.3x
Bluejay Diagnostics, Inc. BJDX ██% $5M x 1.1x
Boston Scientific Corp BSX ██% $69.67B 19.5x 2.7x
Biotricity Inc. BTCY ██% $4M x x
Bioventus Inc. BVS ██% $587M 20.6x 3.1x
Brainsway Ltd. BWAY ██% $567M x x
Carlsmed, Inc. CARL ██% $287M x 3.1x
Cerus Corp CERS ██% $480M x 7.1x
Clearpoint Neuro, Inc. CLPT ██% $400M x 21.2x
Co-Diagnostics, Inc. CODX ██% $14M x 0.9x
Cytosorbents Corp CTSO ██% $33M x 14.8x
Cvrx, Inc. CVRX ██% $129M x 4.4x
Delcath Systems, Inc. DCTH ██% $398M 709.0x 3.5x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $52M x 0.8x
Alpha Tau Medical Ltd. DRTS ██% $823M x 10.7x
Dexcom Inc DXCM ██% $28.23B 30.3x 9.6x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Dynatronics Corp DYNTQ ██% $0.00M x 0.0x
Ebr Systems, Inc. EBRCZ ██% $84M x 8.8x
Encision Inc ECIA ██% $3M x 1.8x
Embecta Corp. EMBC ██% $183M 1.6x x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $12M x 1.6x
Family Office Of America, Inc. FOFA ██% $36M 231.9x 37.6x
Glucotrack, Inc. GCTK ██% $2M x x
Global Innovative Platforms Inc. GIPL ██% $170K x 0.3x
Glaukos Corp GKOS ██% $7.44B x 11.1x
Globus Medical Inc GMED ██% $10.49B 17.9x 2.2x
Fractyl Health, Inc. GUTS ██% $123M x 5.8x
Haemonetics Corp HAE ██% $3.37B 34.6x 4.2x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $20M x 217.9x
Heartflow, Inc. HTFL ██% $2.76B x 9.7x
Integra Lifesciences Holdings Corp IART ██% $1.36B x 1.3x
Icecure Medical Ltd. ICCM ██% $6M x 0.7x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.56B 76.8x 1.7x
Interpace Biosciences, Inc. IDXG ██% $43M 1.8x 1.9x
Qtrex Quantum Ltd. IINN ██% $132M x 56.7x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $6M x 0.6x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.19B 9.1x 1.5x
Iradimed Corp IRMD ██% $1.17B 49.7x 11.9x
Irhythm Holdings, Inc. IRTC ██% $3.58B x 22.2x
Invo Fertility, Inc. IVF ██% $3M x 0.5x
Orthopediatrics Corp KIDS ██% $439M x 1.3x
Kestra Medical Technologies, Ltd. KMTS ██% $1.12B x 3.9x
Koru Medical Systems, Inc. KRMD ██% $182M x 10.7x
Lemaitre Vascular Inc LMAT ██% $2.13B 34.2x 5.3x
Lensar, Inc. LNSR ██% $75M 2.5x 6.9x
Lucid Diagnostics Inc. LUCD ██% $195M x 48.7x
Pulmonx Corp LUNG ██% $53M x 1.2x
Lyra Therapeutics, Inc. LYRA ██% $1M x x
Microbot Medical Inc. MBOT ██% $122M x 1.7x
Mountain Crest Acquisition Corp. V MCAG ██% $37M x x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $58M x x
Medline Inc. MDLN ██% $66.09B 78.9x 5.9x
Medinotec Inc. MDNC ██% $59M 74.0x 10.3x
Mimedx Group, Inc. MDXG ██% $551M 18.0x 2.3x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $84.30B 30.3x 25.8x
Merit Medical Systems Inc MMSI ██% $4.04B 29.0x 2.5x
Modular Medical, Inc. MODD ██% $27M x 4.5x
Nephros Inc NEPH ██% $35M 44.6x 3.2x
Neuroone Medical Technologies Corp NMTC ██% $28M x 5.5x
Neuropace Inc NPCE ██% $509M x 35.2x
Inspiremd, Inc. NSPR ██% $33M x 0.8x
Nu-Med Plus, Inc. NUMD ██% $790K x x
Novocure Ltd NVCR ██% $2.03B x 6.1x
Envveno Medical Corp NVNO ██% $7M x 0.3x
Nexgel, Inc. NXGL ██% $4M x 1.1x
Nyxoah Sa NYXH ██% $158M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $226M x 5.5x
Odyssey Health, Inc. ODYY ██% $1M x x
Orthofix Medical Inc. OFIX ██% $380M x 0.9x
Osr Holdings, Inc. OSRH ██% $12M x 0.1x
Orasure Technologies Inc OSUR ██% $300M x 1.0x
Pavmed Inc. PAVM ██% $36M x 0.9x
Pro Dex Inc PDEX ██% $199M 16.6x 4.4x
Penumbra Inc PEN ██% $12.50B 73.1x 8.5x
Petvivo Holdings, Inc. PETV ██% $29M x 8.7x
Profusa, Inc. PFSA ██% $1M x x
Polyrizon Ltd. PLRZ ██% $21M x 1.0x
Pulse Biosciences, Inc. PLSE ██% $1.77B x 26.7x
Picard Medical, Inc. PMI ██% $17M x x
Insulet Corp PODD ██% $10.48B 34.6x 8.0x
Procept Biorobotics Corp PRCT ██% $1.32B x 3.8x
Premier Air Charter Holdings Inc. PREM ██% $2M x 0.6x
Profound Medical Corp. PROF ██% $244M x 4.1x
Plus Therapeutics, Inc. PSTV ██% $34M x 2.9x
Polypid Ltd. PYPD ██% $85M x 7.7x
Qtrex Quantum Ltd. QTEX ██% $100M x 42.9x
Avita Medical, Inc. RCEL ██% $121M x x
Vivos Inc RDGL ██% $32M x 11.9x
Resmed Inc RMD ██% $28.18B 18.6x 4.3x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $75M x x
Retractable Technologies Inc RVP ██% $20M x 0.3x
Sight Sciences, Inc. SGHT ██% $271M x 5.0x
Si-Bone, Inc. SIBN ██% $668M x 3.7x
Sigyn Therapeutics, Inc. SIGY ██% $60K x x
Sintx Technologies, Inc. SINT ██% $14M x 15.2x
Skinhealth Systems Inc. SKIN ██% $85M x 1.5x
Sonoma Pharmaceuticals, Inc. SNOA ██% $4M x 1.1x
Sanuwave Health, Inc. SNWV ██% $128M 8.0x 69.7x
Solventum Corp SOLV ██% $13.69B 9.6x 2.8x
Sensus Healthcare, Inc. SRTS ██% $45M x 1.0x
Ss Innovations International, Inc. SSII ██% $672M x 12.3x
Strata Skin Sciences, Inc. SSKN ██% $710K x 0.2x
Neuronetics, Inc. STIM ██% $88M x 6.7x
Stimcell Energetics Inc. STME ██% $7M x x
Skyai, Inc. STSS ██% $61M x 0.3x
Stevanato Group S.P.A. STVN ██% $4.54B x x
Stryker Corp SYK ██% $119.69B 35.9x 5.2x
Tactile Systems Technology Inc TCMD ██% $601M 29.6x 2.8x
Tela Bio, Inc. TELA ██% $35M x x
Teleflex Inc TFX ██% $5.77B x 1.9x
Trisalus Life Sciences, Inc. TLSI ██% $258M x 20.1x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $247M x 3.2x
Tandem Diabetes Care Inc TNDM ██% $1.15B x 8.7x
Tenon Medical, Inc. TNON ██% $7M x 3.7x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.80B 26.2x 4.1x
Qhslab, Inc. USAQ ██% $5M 12.2x 3.5x
Utah Medical Products Inc UTMD ██% $224M 20.7x 1.9x
Venus Concept Inc. VERO ██% $580K x 0.2x
Catheter Precision, Inc. VTAK ██% $3M x 0.3x
Vivos Therapeutics, Inc. VVOS ██% $8M x x
Vycor Medical Inc VYCO ██% $2M x x
West Pharmaceutical Services Inc WST ██% $23.37B 43.1x 7.8x
Beyond Air, Inc. XAIR ██% $5M x 0.6x
Xtant Medical Holdings, Inc. XTNT ██% $61M 33.7x 1.3x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Stryker Corp Stock Forecast

How accurate are Stryker Corp stock predictions?

Our AI model shows a -24% Spearman correlation coefficient for SYK predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Stryker Corp stock price forecasts?

Our analysis considers Stryker Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Stryker Corp a good investment in 2025?

Based on our AI analysis, Stryker Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Stryker Corp forecasts updated?

Stryker Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Stryker Corp?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...